Screening With a DNA Blood Test to Address Colorectal Cancer Inequities (NCT06929481)
Screening With Liquid Biopsies to Address Colorectal Cancer Inequities
🩺 Plain-English Summary (8th-Grade Level)
Colorectal cancer (CRC) screening participation is suboptimal and associated with inequities in CRC outcomes by race/ethnicity and socioeconomic position. A novel, cell free DNA (cfDNA) blood test has potential to increase participation, but has not been studied in groups at highest risk for adverse CRC outcomes. Among patients age-eligible for colorectal cancer screening, not up-to-date, we propose a 2-arm, pragmatic, randomized controlled trial comparing offers of standard screening options (at home fecal immunochemical test (FIT) or colonoscopy) vs. offers of expanded options (at home FIT, colonoscopy, or in clinic cfDNA plus at home FIT), set at a large Federally Qualified Health Center serving individuals at increased risk for inequities in CRC outcomes. Results will inform guideline and policy makers on whether cfDNA should be supported as a screening option, and support planning for a large-scale trial examining impact of a cfDNA option for screening on CRC and advanced neoplasia detection.
Who can join: Review the eligibility criteria below.
Location: Family Health Centers of San Diego, Logan Heights site — San Diego, California
Age range: 45 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Family Health Centers of San Diego, Logan Heights site — San Diego, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer Screening
- Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening — Rome, Georgia
- Impact of Protect Your Colon™ on CRC Screening — Los Angeles, California
- Animated Storytelling to Promote Colorectal Cancer Screening — Stanford, California
- Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection — Austin, Texas
- Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test — Morrisville, North Carolina
Explore by condition: All Colorectal Cancer Screening clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.